Monday 22 June, 3:30pm - 4:00pmon NHK World Europe

Medical Frontiers

GLP-1 Drugs for Obesity: Benefits and Risks

Explores the impact of GLP-1 receptor agonists on obesity management, while highlighting the significant risks associated with unsupervised use and the wider therapeutic potential of these treatments.

Cast and crew
  • Erica Angyal